期刊文献+

乙酰辅酶A羧化酶抑制剂对肥胖小鼠的减肥效果 被引量:5

Effects of Acetyl-CoA Carboxylase Inhibitor on the Obesity Mice
下载PDF
导出
摘要 [目的]研究乙酰辅酶A羧化酶抑制剂对肥胖小鼠肥胖程度的影响。[方法]建立肥胖动物模型,然后随机分组,试验组以乙酰辅酶A羧化酶抑制剂按照50mg/(kg.bw.d)的剂量灌胃,对照组小鼠以去离子水灌胃。给药过程中,记录小鼠采食量和饮水量的变化情况。给药3周后,测定体重和体长,进行李氏指数的计算;称量脂肪,计算性器官周围脂肪占小鼠体重的比重;测定血清中胆固醇和甘油三酯的相对含量。[结果]乙酰辅酶A羧化酶抑制剂能抑制小鼠体重的增加,可减少肥胖小鼠的肥胖程度;能降低肥胖小鼠血清中的甘油三酯和胆固醇含量。[结论]乙酰辅酶A羧化酶抑制剂对肥胖小鼠有减肥作用,对小鼠的正常饮食没有明显影响。 [ Objective ] The research aimed to investigate the effect of the Acetyl-CoA carboxylase inhibitor on the obesity degree of obesity mice. [Method] The obesity animal model was established and mice were randomly divided. Mice in test group was fed with Acetyl-CoA carboxylase inhibitor with the dose of 50 mg/(kg, bw-d)by intragastric administration and mice in control group was treated with deionized water by intragastric administration. The changes of the feed intake and drinking amount of mice in the administration process were recorded. Mice were anatomize after administration three weeks.The body weight and body length were determined, and Lee's index was calculated. The fat was weighed and the proportion of the fat around the sexual organs in the body weight of mice was calculated. The relative contention of cholesterol and triglyceride in the serum was measured. [ Result ] Acetyl-CoA carboxylase inhibitor could inhibit the weight increase of mice, reduce the obese degree of obesity mice and decrease the contents of triglyceride and cholesterol in the serum of obesity mice. [ Conclusion ] Acetyl-CoA carboxylase inhibitor had the slimming action on obesity mice, but it had no obvious effect on the normal diet of obesity mice.
机构地区 延边大学农学院
出处 《畜牧与饲料科学》 2012年第7期10-13,共4页 Animal Husbandry and Feed Science
基金 延边大学第四届大学生科研立项课题
关键词 乙酰辅酶A羧化酶抑制剂 减肥作用 肥胖小鼠 Acetyl-CoA carboxylase inhibitors slimming action obesity mice
  • 相关文献

参考文献16

  • 1FUKUHARA A,MATSUDA M,NISHIZAWA M,et al. Visfatin :a protein secreted by visceral fat that mimics the effects of insulin [ J ].Science, 2005,307 (5708) :426-430. 被引量:1
  • 2刘丽芳,戴丽明.泽根减肥汤对营养性肥胖大鼠减肥作用的研究[J].中国老年学杂志,2010,30(9):1261-1262. 被引量:2
  • 3LIVAK K J,SCHMITYGEN T D.Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△CT Method [ J ] .Methods, 2001,25 (4) : 402-408. 被引量:1
  • 4FEINLEIB M.Epidemiology of obesity in relation to health hazards [J ].Ann Intern Med, 1985,103(6) : 1019-1024. 被引量:1
  • 5WEISBERG S P,McCANN D,DESAI M,et al.Obesity is associated with macrophage accumulation in adipose tissue [J].J Clin Invest,2003,112(12) : 1796-1808. 被引量:1
  • 6BERNDT J,KLOTING N,KRALISCH S,et al.Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [J].Diabetes,2005,54 (10) :2911 - 2916. 被引量:1
  • 7BRAY G A.Contemporary Diagnosis and Management of Obesity [ M ].Newtown : Handbooks in Health Care Company, 1998:1-393. 被引量:1
  • 8MUST A,SPADANO J,COAKLEY E H,et al.The disease burden associated with overweight and obesity [J].JAMA, 1999,282(16) : 1523-1529. 被引量:1
  • 9周予昭,黄仲义.减肥药的现状与评价[J].中国药房,2000,11(4):168-169. 被引量:9
  • 10李亮,程彦伟.乙酰辅酶A羧化酶在治疗肥胖中的潜在作用[J].生命的化学,2007,27(2):180-182. 被引量:19

二级参考文献66

  • 1杨义生,洪洁.减肥药物的应用及研发现状[J].世界临床药物,2003,24(11):653-657. 被引量:5
  • 2钱伯初,刘雪莉,臧星星,陈珏,许衡钧,李兰妹.花粉对谷氨酸钠所致小鼠肥胖的预防作用[J].中国病理生理杂志,1993,9(3):430-433. 被引量:8
  • 3刘光珍,牛天福,侯振民,阎润红,王世民.耄塞通的药效学实验研究[J].中医药研究,1994,10(1):48-49. 被引量:7
  • 4谷贵文,刘兵.甲壳素及壳聚糖的医药应用[J].黑龙江医药,1996,9(4):184-185. 被引量:6
  • 5沈稚舟 陈灏珠.肥胖症.实用内科学(第10版)[M].北京:人民卫生出版社,1997.872. 被引量:1
  • 6章鸣.早期研究开发中的新减肥药[J].国外药讯,1998,10(9):41-41. 被引量:2
  • 7Kim E K, Miller I, Landree L E, et al. Expression of FAS within hypothalamic neurons: amodel for decreased food intake afterC75 treatment[J]. Am J Physiol Endocrinol Metab, 2002,283:E867-E879. 被引量:1
  • 8Obici S, Feng Z, Arduini A, et al. Inhibition ofhypothalamic carnitine palmitoyltransferase-I decreases food intake and glucose production[J]. Nat Med, 2003,9(6):756-761. 被引量:1
  • 9Loftus T M, Jaworsky D E, Frehywot G L, et al. Reduced food intake and bodyweight inmice treatedwith fatty acid synthase inhibitors[J]. Science, 2000,288(5475):2379-2381. 被引量:1
  • 10Kumar M V, Shimokawa T, Nagy T R, et al. Differential effects of acentrally acting fatty acid synthase inhibitor in lean and obese mice[J]. Proc Natl Acad Sci U S A, 2002,99(4):1921-1925. 被引量:1

共引文献153

同被引文献40

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部